Nomura Holdings’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Nomura Holdings’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,115,015	Closed	-$49.1M	–	2489
2024 Q4	$49.1M	Buy	+5,115,015	New	+$26.7M	0.07%	154

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nomura Holdings's PSTX Position: Q1 2025 in Review

Nomura Holdings sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 5,115,015 shares — an estimated $49.1M sold.

Nomura Holdings first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $49.1M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Nomura Holdings reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Nomura Holdings sold 5,115,015 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $49.1M.
Nomura Holdings first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Nomura Holdings's Poseida Therapeutics, Inc. Common Stock position peaked at $49.1M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.